Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$8.63 - $12.56 $10,399 - $15,134
1,205 Added 10.09%
13,150 $122,000
Q1 2024

May 14, 2024

BUY
$9.86 - $13.74 $117,777 - $164,124
11,945 New
11,945 $147,000
Q2 2023

Apr 29, 2024

BUY
$8.59 - $14.56 $102,607 - $173,919
11,945 New
11,945 $114,000
Q1 2023

May 09, 2024

BUY
$9.53 - $16.8 $113,835 - $200,676
11,945 New
11,945 $143 Million
Q3 2022

May 10, 2024

BUY
$7.19 - $9.91 $85,884 - $118,374
11,945 New
11,945 $108,000
Q3 2022

Mar 22, 2023

BUY
$7.19 - $9.91 $31,758 - $43,772
4,417 Added 58.67%
11,945 $108,000
Q3 2022

Nov 14, 2022

BUY
$7.19 - $9.91 $85,884 - $118,374
11,945 New
11,945 $108,000
Q4 2021

Feb 15, 2022

SELL
$8.71 - $13.77 $65,568 - $103,660
-7,528 Closed
0 $0
Q3 2021

May 17, 2024

SELL
$10.35 - $15.65 $45,715 - $69,126
-4,417 Reduced 36.98%
7,528 $77,000
Q3 2021

Jun 21, 2023

SELL
$10.35 - $15.65 $45,715 - $69,126
-4,417 Reduced 36.98%
7,528 $77,000
Q3 2021

Mar 22, 2023

SELL
$10.35 - $15.65 $5,661 - $8,560
-547 Reduced 6.77%
7,528 $77,000
Q3 2021

Nov 15, 2021

BUY
$10.35 - $15.65 $77,914 - $117,813
7,528 New
7,528 $86,000
Q4 2020

Feb 16, 2021

SELL
$11.65 - $17.94 $94,073 - $144,865
-8,075 Closed
0 $0
Q3 2020

Jun 26, 2023

SELL
$12.98 - $25.98 $50,232 - $100,542
-3,870 Reduced 32.4%
8,075 $128,000
Q2 2020

May 24, 2024

SELL
$9.06 - $23.49 $35,062 - $90,906
-3,870 Reduced 32.4%
8,075 $201 Million
Q2 2020

Jun 26, 2023

SELL
$9.06 - $23.49 $35,062 - $90,906
-3,870 Reduced 32.4%
8,075 $182,000
Q1 2020

Jul 12, 2023

SELL
$7.2 - $13.09 $27,864 - $50,658
-3,870 Reduced 32.4%
8,075 $81,000
Q1 2020

Mar 22, 2023

SELL
$7.2 - $13.09 $27,864 - $50,658
-3,870 Reduced 32.4%
8,075 $81,000
Q1 2020

May 15, 2020

BUY
$7.2 - $13.09 $58,140 - $105,701
8,075 New
8,075 $89,000

Others Institutions Holding ZYXI

About ZYNEX INC


  • Ticker ZYXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 37,453,400
  • Market Cap $293M
  • Description
  • Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...
More about ZYXI
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.